MWP
SEEL

MYCIO Wealth Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

MYCIO Wealth Partners’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8
Closed -$41K – 436
2019
Q4 		$41K Buy
8
+2
+33% +$7.67K ﹤0.01% 403
2019
Q3 		$22K Buy
+6
New +$36.2K ﹤0.01% 405

Other funds holding SEEL

UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MYCIO Wealth Partners's SEEL Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2020, closing a stake of 8 shares — an estimated $41K sold.

MYCIO Wealth Partners first reported a position in SEEL in Q3 2019 and held it in 2 quarters. The position peaked at $41K in Q4 2019. 20 funds tracked by Wall St. Rank hold SEEL as of Q1 2020.

  • MYCIO Wealth Partners reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • MYCIO Wealth Partners sold 8 Seelos Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $41K.
  • MYCIO Wealth Partners first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • MYCIO Wealth Partners's Seelos Therapeutics, Inc. Common Stock position peaked at $41K in Q4 2019.
  • 20 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.